Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,973,130 papers from all fields of science
Search
Sign In
Create Free Account
Cytomegalovirus Vaccines
Known as:
Cytomegalovirus Vaccines [Chemical/Ingredient]
, Vaccines, Cytomegalovirus
Vaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
In Blood
Process of secretion
agonists
antagonists & inhibitors
Expand
Narrower (1)
V-5 immunitor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
J. Debruyn
,
I. Soon
,
+6 authors
I. Wrobel
Inflammatory Bowel Diseases
2018
Corpus ID: 54632563
BACKGROUND Data on the serologic status of childhood vaccines, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), are limited in…
Expand
2017
2017
New Vaccines in Pipeline Development
P. Heath
,
C. Jones
,
K. L. Doare
2017
Corpus ID: 79852304
Group B streptococcus vaccines Cytomegalovirus vaccines Respiratory syncytial virus vaccines
2011
2011
Neutralizing Activity of Saliva against Cytomegalovirus
Frances M. Saccoccio
,
M. Gallagher
,
S. Adler
,
M. McVoy
Clinical and Vaccine Immunology
2011
Corpus ID: 41178026
ABSTRACT Congenital cytomegalovirus (CMV) disease is the leading cause of permanent disability in neonates in the United States…
Expand
Review
2011
Review
2011
A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines.
Aimin Tang
,
Fengsheng Li
,
+4 authors
T. Fu
Vaccine
2011
Corpus ID: 205587527
2010
2010
Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.
M. Schleiss
Journal of Clinical Investigation
2010
Corpus ID: 29388616
The magnitude and durability of immunity to human cytomegalovirus (HCMV) following natural infection is compromised by the…
Expand
2009
2009
A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus…
M. Crumpler
,
K. Y. Choi
,
M. McVoy
,
M. Schleiss
Vaccine
2009
Corpus ID: 205578964
2007
2007
Human cytomegalovirus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
A. Arvin
,
G. Campadelli-Fiume
,
+4 authors
K. Yamanishi
2007
Corpus ID: 88684337
Review
2005
Review
2005
Progress toward an elusive goal: current status of cytomegalovirus vaccines
M. Schleiss
,
T. Heineman
Expert Review of Vaccines
2005
Corpus ID: 5100637
Although infection with human cytomegalovirus (CMV) is ubiquitous and generally asymptomatic in most individuals, certain patient…
Expand
Review
2005
Review
2005
Immunisation in the current management of cystic fibrosis patients.
A. Malfroot
,
G. Adam
,
+6 authors
A. Bush
Journal of Cystic Fibrosis
2005
Corpus ID: 20998670
Highly Cited
1996
Highly Cited
1996
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
J. B. Wang
,
S. Adler
,
+4 authors
S. Plotkin
Journal of Infectious Diseases
1996
Corpus ID: 16248683
Because antibodies against human cytomegalovirus (HCMV) glycoprotein B (gB) neutralize, levels of IgG, secretory IgA (sIgA), and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE